OESOPHAGEAL CARCINOMA RECURRENT

OESOPHAGEAL CARCINOMA RECURRENT was reported 86 times

These drug classes are most commonly taken by patients reporting OESOPHAGEAL CARCINOMA RECURRENT:

# Drug Count
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 31
1 Platinum-based Drug [EPC] 22
2 Nucleoside Metabolic Inhibitor [EPC] 18
3 Insulin Analog [EPC] 7
4 Corticosteroid [EPC] 6
5 Microtubule Inhibitor [EPC] 5
6 CD20-directed Cytolytic Antibody [EPC] 3
7 Factor Xa Inhibitor [EPC] 3
8 HER2/neu Receptor Antagonist [EPC] 3
9 Leukocyte Growth Factor [EPC] 3
10 Nonsteroidal Anti-inflammatory Drug [EPC] 3
11 Opioid Agonist [EPC] 3
12 Proton Pump Inhibitor [EPC] 3
13 Atypical Antipsychotic [EPC] 2
14 Azole Antifungal [EPC] 2
15 CTLA-4-directed Blocking Antibody [EPC] 2
16 Calcineurin Inhibitor Immunosuppressant [EPC] 2
17 Dihydropyridine Calcium Channel Blocker [EPC] 2
18 HMG-CoA Reductase Inhibitor [EPC] 2
19 Integrin Receptor Antagonist [EPC] 2
20 Interferon beta [EPC] 2
21 Topoisomerase Inhibitor [EPC] 2
22 Tumor Necrosis Factor Blocker [EPC] 2
23 Alkylating Drug [EPC] 1
24 Amide Local Anesthetic [EPC] 1
25 Angiotensin 2 Receptor Blocker [EPC] 1
26 Anti-IgE [EPC] 1
27 Anti-epileptic Agent [EPC] 1
28 Antiarrhythmic [EPC] 1
29 Aromatase Inhibitor [EPC] 1
30 Benzodiazepine [EPC] 1
31 Calcium Channel Blocker [EPC] 1
32 Calcium [EPC] 1
33 Echinocandin Antifungal [EPC] 1
34 Epidermal Growth Factor Receptor Antagonist [EPC] 1
35 Ester Local Anesthetic [EPC] 1
36 Expectorant [EPC] 1
37 Folate Analog Metabolic Inhibitor [EPC] 1
38 Glycopeptide Antibacterial [EPC] 1
39 Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] 1
40 Mood Stabilizer [EPC] 1
41 Non-Standardized Chemical Allergen [EPC] 1
42 Oxazolidinone Antibacterial [EPC] 1
43 Parathyroid Hormone Analog [EPC] 1
44 Platelet Aggregation Inhibitor [EPC] 1
45 Programmed Death Ligand-1 Blocker [EPC] 1
46 Selective T Cell Costimulation Modulator [EPC] 1
47 Stimulant Laxative [EPC] 1
48 Thalidomide Analog [EPC] 1
49 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
50 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1